BKYI
BIO-key International, Inc.
BKYI's outlook is improving, though it still trails on the overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over BKYI overall, supported by stronger fundamentals and lower modeled downside.
BKYI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
BKYI's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
BKYI PE Valuation
BKYI has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
BKYI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BKYI's losses to shrink, with revenue growing.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BKYI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$7.93 | +$3.37 |
| Q1 2026 | -$9.37 | +$9.93 |
| Q4 2025 | -$10.77 | +$10.13 |
| Q3 2025 | -$8.90 | +$53.20 |
| Q2 2025 | -$11.30 | +$59.50 |
| Q1 2025 | -$19.30 | +$70.30 |
| Q4 2024 | -$20.90 | +$70.90 |
| Q3 2024 | -$62.10 | +$135.55 |
BKYI has the edge over RKLB on earnings, with more consistent year-over-year improvement.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
BKYI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.9M | +13% |
| Q1 2026 | $2.1M | +33% |
| Q4 2025 | $1.1M | -26% |
| Q3 2025 | $1.5M | -28% |
| Q2 2025 | $1.7M | +49% |
| Q1 2025 | $1.6M | -26% |
| Q4 2024 | $1.5M | -20% |
| Q3 2024 | $2.1M | +18% |
BKYI's revenue is recovering but still below its 2023 peak: $2M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -28% | +36 points |
| Q1 2026 | -7.3% | +33 points |
| Q4 2025 | -389% | -302 points |
| Q3 2025 | -58% | -31 points |
| Q2 2025 | -64% | +81 points |
| Q1 2025 | -40% | -17 points |
| Q4 2024 | -87% | +63 points |
| Q3 2024 | -27% | +15 points |
BKYI has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over BKYI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
BKYI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$845.7K | +$35.7K |
| Q1 2026 | -$358K | +$481.9K |
| Q4 2025 | -$1.8M | -$1.3M |
| Q3 2025 | -$1.1M | +$173.1K |
| Q1 2025 | -$839.9K | -383% |
| Q4 2024 | -$504.6K | +$1M |
| Q3 2024 | -$1.3M | -$1.1M |
| Q1 2024 | $297.1K | +$2.2M |
BKYI has the edge over RKLB on cash flow, with more consistent year-over-year improvement.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
BKYI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +2K shares |
| 1 year | +121% | +567K shares |
| 3 years | +2191% | +992K shares |
| 5 years | +7058% | +1M shares |
BKYI has 1M diluted shares, up 121% from a year ago.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has the edge over BKYI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
BKYI Net Leverage
BKYI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BKYI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.9 | Neutral |
| Stochastic | 29.9 | Neutral |
BKYI's weekly RSI is 42 (neutral) and its Stochastic is 30 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
BKYI PE vs Industrials Sector
BKYI has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
BKYI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.41 | 7.1% above |
| 20 week MA | $3.16 | 18% below |
| 50 week MA | $4.70 | 45% below |
| 100 week MA | $7.00 | 63% below |
| 200 week MA | $33.8 | 92% below |
BKYI has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 92% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over BKYI on trend strength, trading above more of its moving averages.
BKYI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $705.9 | $624.6 | -12% |
| 2021 | $624.6 | $417.6 | -33% |
| 2022 | $417.6 | $108.1 | -74% |
| 2023 | $108.1 | $30.0 | -72% |
| 2024 | $30.0 | $14.1 | -53% |
| 2025 | $14.1 | $6.06 | -57% |
| 2026 YTD | $6.06 | $2.58 | -57% |
BKYI has finished every year since 2020 lower, and it's down 57% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over BKYI on returns for 2026, with the stronger performance.